ADC Therapeutics (ADCT) Times Interest Earned (2020 - 2026)
ADC Therapeutics (ADCT) posted Times Interest Earned of -$2.04 for Q1 2026, up 11.6% sequentially from -$2.31 in Q3 2025, and up 12.16% YoY from -$1.82 in Q1 2025.
ADC Therapeutics (ADCT) Times Interest Earned (2020 - 2026) Analysis & Trends
ADC Therapeutics has reported Times Interest Earned for 7 years, with the latest figure at -$2.04 in Q1 2026.
- Quarterly Times Interest Earned rose 12.16% year-over-year to -$2.04 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.83 (down 191.33% YoY) and the FY2022 annual result came in at -$0.16, up 98.59% from the prior year.
- Times Interest Earned improved to -$2.04 in Q1 2026 per ADCT's latest filing, from -$2.31 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$0.27 in Q3 2022 and troughed at -$7.89 in Q2 2022.
- A 5-year average of -$3.32 and a median of -$2.77 in 2023 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2023: Times Interest Earned surged 97.98% in 2022, then tumbled 928.61% in 2023.
- Over 5 years, Times Interest Earned stood at -$4.58 in 2022, then surged by 38.4% to -$2.82 in 2023, then advanced by 3.88% to -$2.71 in 2024, then climbed by 14.71% to -$2.31 in 2025, then rose by 11.6% to -$2.04 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$2.04, -$2.31, and -$3.4 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | ADC Therapeutics | 154.55 Mn | -64.56 Mn | 17.14 Mn | -1.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.88 |
| Mar 31, 2026 | -2.04 |
| Sep 30, 2025 | -2.31 |
| Jun 30, 2025 | -3.40 |
| Mar 31, 2025 | -2.33 |
| Sep 30, 2024 | -2.71 |
| Jun 30, 2024 | -2.29 |
| Mar 31, 2024 | -2.69 |
| Sep 30, 2023 | -2.82 |
| Jun 30, 2023 | -3.85 |
| Mar 31, 2023 | -4.95 |
| Dec 31, 2022 | -4.58 |
| Sep 30, 2022 | -0.27 |
| Jun 30, 2022 | -7.89 |
| Mar 31, 2022 | -4.38 |
| Dec 31, 2021 | -2.73 |
| Sep 30, 2021 | -13.55 |
| Jun 30, 2021 | -27.59 |
| Mar 31, 2021 | -31.85 |
| Dec 31, 2020 | -26.48 |